(Senior) Medical Science Liaison - East New England
TempusSalary not specified
Full Time
Senior (5 to 8 years)
Not SpecifiedCompensation
Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Biotechnology, Pharmaceuticals, HealthcareIndustries
Requirements
Candidates should possess an advanced degree in health sciences (PharmD, M.D., or Ph.D. in a medically related field) with at least 2 years of experience in hematologic malignancy or cell therapy, or a Master's degree with extensive clinical/medical affairs experience. A minimum of 2 years of MSL/Medical Affairs experience in a relevant therapeutic area is required, along with familiarity with healthcare systems and access environments. Strong partnering, influencing, communication, and presentation skills are essential, as is a results-oriented and adaptable mindset. The ideal candidate will reside within the New England territory.
Responsibilities
The Medical Science Liaison will establish and maintain relationships with healthcare professionals in the hematology space through in-person and virtual interactions. They will develop and execute territory plans, partner with field-based teams for customer service, and deliver approved medical and scientific education. Responsibilities also include collecting insights from thought leaders to inform medical strategies, representing the company at conferences, and supporting clinical trial execution. Approximately 50-70% domestic travel is expected.
Skills
Cell Therapy
Medical Affairs
Scientific Exchange
Medical Education
Thought Leader Engagement
Insight Collection
Arcellx
Develops immunotherapies for cell therapy
About Arcellx
Arcellx develops immunotherapies aimed at improving cell therapy for serious diseases. Their products focus on advanced techniques that enhance the effectiveness of treatments. The company collaborates with healthcare providers and research institutions to bring these therapies to patients. Unlike many competitors, Arcellx emphasizes proprietary products and partnerships to drive their research and development efforts. The goal is to meet unmet medical needs by providing safe and effective treatment options through their innovative approach to cell therapy.
Gaithersburg, MarylandHeadquarters
2014Year Founded
$194.5MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
51-200Employees